BIOTECH RESOURCES GROUP, LLC

biotechresources.us

Since 2000, Biotech Resources Group has been providing placement services to our Pharma, Biotech & CRO clients. Areas of specialty include: Clinical Research, Medical Affairs, Regulatory Affairs & Biotech Manufacturing. Services include: sourcing, qualifying, screening candidates per client's job requirements. In addition, we will perform reference checks, assist candidates with resume formatting and any other appropriate task necessary in assisting our Clients find the best talent for their organizations.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Medical

LIGHT BIO PARTNERS WITH GINKGO BIOWORKS TO OPTIMIZE THE BRIGHTNESS OF GLOWING PLANTS THROUGH BIOLUMINESCENCE ENGINEERING

Light Bio | April 18, 2022

news image

Light Bio, Inc., a company that is creating bioluminescent plants for home and garden, and Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced a collaboration to leverage Ginkgo's plant cell assays for bioluminescence engineering. Through the agreement, Ginkgo aims to help improve the luminescent output and efficiency of the enzymes within Light Bio's glowing ornamental plants. The scientists at Light Bio have discovered a new...

Read More

Medical, Industry Outlook

TRIRX PARTNERSHIP WITH LIVERPOOL CITY REGION ADVANCES BIOTECH CAPABILITIES

PRNewswire | July 31, 2023

news image

TriRx Pharmaceutical Services, LLC, a Contract Development and Manufacturing Organization (CDMO), welcomed the UK Government's recent announcement on England's second Investment Zone, focused on Life Sciences in the Liverpool City Region. TriRx Speke Ltd. is the first investor and is well-positioned to further advance its capabilities by adding upstream technologies to manufacture monoclonal antibodies to an existing large-scale biotech purification facility. The current...

Read More

Medical, Industry Outlook

MUSTANG BIO ANNOUNCES FIRST DATA FROM ONGOING MULTICENTER PHASE 1/2 CLINICAL TRIAL EVALUATING MB-106 CAR-T CELL THERAPY

Globenewswire | August 17, 2023

news image

Mustang Bio Inc. a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for difficult-to-treat cancers and rare genetic diseases, today announced the first data from the indolent lymphoma cohort of the Company’s ongoing multicenter Phase 1/2 clinical trial evaluating MB-106, a first-in-class CD20-targeted, autologous CAR-T cell therapy for the treatment of relapsed or refractory B-cell non-...

Read More

Industrial Impact

IFF TO ACQUIRE HEALTH WRIGHT PRODUCTS

IFF | February 17, 2022

news image

IFF announced that it has entered into an agreement to acquire Health Wright Products, LLC (HWP), a leader in formulation and capsule manufacturing for the dietary supplement industry. Founded in 1995, HWP is located in Clackamas, Oregon, USA, and is a privately-owned and long-time business partner of IFF’s Health & Biosciences probiotics business. HWP is a global leader in the consumer Health and Nutrition industries, providing the highest-quality nutritional supplement...

Read More
news image

Medical

LIGHT BIO PARTNERS WITH GINKGO BIOWORKS TO OPTIMIZE THE BRIGHTNESS OF GLOWING PLANTS THROUGH BIOLUMINESCENCE ENGINEERING

Light Bio | April 18, 2022

Light Bio, Inc., a company that is creating bioluminescent plants for home and garden, and Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced a collaboration to leverage Ginkgo's plant cell assays for bioluminescence engineering. Through the agreement, Ginkgo aims to help improve the luminescent output and efficiency of the enzymes within Light Bio's glowing ornamental plants. The scientists at Light Bio have discovered a new...

Read More
news image

Medical, Industry Outlook

TRIRX PARTNERSHIP WITH LIVERPOOL CITY REGION ADVANCES BIOTECH CAPABILITIES

PRNewswire | July 31, 2023

TriRx Pharmaceutical Services, LLC, a Contract Development and Manufacturing Organization (CDMO), welcomed the UK Government's recent announcement on England's second Investment Zone, focused on Life Sciences in the Liverpool City Region. TriRx Speke Ltd. is the first investor and is well-positioned to further advance its capabilities by adding upstream technologies to manufacture monoclonal antibodies to an existing large-scale biotech purification facility. The current...

Read More
news image

Medical, Industry Outlook

MUSTANG BIO ANNOUNCES FIRST DATA FROM ONGOING MULTICENTER PHASE 1/2 CLINICAL TRIAL EVALUATING MB-106 CAR-T CELL THERAPY

Globenewswire | August 17, 2023

Mustang Bio Inc. a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for difficult-to-treat cancers and rare genetic diseases, today announced the first data from the indolent lymphoma cohort of the Company’s ongoing multicenter Phase 1/2 clinical trial evaluating MB-106, a first-in-class CD20-targeted, autologous CAR-T cell therapy for the treatment of relapsed or refractory B-cell non-...

Read More
news image

Industrial Impact

IFF TO ACQUIRE HEALTH WRIGHT PRODUCTS

IFF | February 17, 2022

IFF announced that it has entered into an agreement to acquire Health Wright Products, LLC (HWP), a leader in formulation and capsule manufacturing for the dietary supplement industry. Founded in 1995, HWP is located in Clackamas, Oregon, USA, and is a privately-owned and long-time business partner of IFF’s Health & Biosciences probiotics business. HWP is a global leader in the consumer Health and Nutrition industries, providing the highest-quality nutritional supplement...

Read More